These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23192371)

  • 21. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?
    Zhou M; Aydin H; Kanane H; Epstein JI
    Am J Surg Pathol; 2004 Feb; 28(2):239-43. PubMed ID: 15043314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of MCT2 at peroxisomes is associated with malignant transformation in prostate cancer.
    Valença I; Pértega-Gomes N; Vizcaino JR; Henrique RM; Lopes C; Baltazar F; Ribeiro D
    J Cell Mol Med; 2015 Apr; 19(4):723-33. PubMed ID: 25639644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
    Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ
    Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score.
    Murphy AJ; Hughes CA; Lannigan G; Sheils O; O'Leary J; Loftus B
    Histopathology; 2007 Jan; 50(2):243-51. PubMed ID: 17222253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens.
    Trpkov K; Bartczak-McKay J; Yilmaz A
    Am J Clin Pathol; 2009 Aug; 132(2):211-20; quiz 307. PubMed ID: 19605815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.
    Jiang Z; Li C; Fischer A; Dresser K; Woda BA
    Am J Clin Pathol; 2005 Feb; 123(2):231-6. PubMed ID: 15842047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies.
    Vanguri VK; Woda BA; Jiang Z
    Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):365-8. PubMed ID: 16932031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate.
    Adley BP; Yang XJ
    Am J Clin Pathol; 2006 Dec; 126(6):849-55. PubMed ID: 17074684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. alpha-methylacyl coenzyme A racemase is immunoreactive in extramammary Paget disease.
    Mayes DC; Patterson JW; Ramnani DM; Mills SE
    Am J Clin Pathol; 2007 Apr; 127(4):567-71. PubMed ID: 17369131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.
    Carswell BM; Woda BA; Wang X; Li C; Dresser K; Jiang Z
    Histopathology; 2006 May; 48(6):668-73. PubMed ID: 16681682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
    Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
    JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study.
    Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H
    Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of racemase and other immunomarkers in the detection of adenocarcinoma in prostatic tissue damaged by high intensity focused ultrasound therapy.
    Dalfior D; Delahunt B; Brunelli M; Parisi A; Ficarra V; Novara G; Novella G; Gobbo S; Valotto C; Chilosi M; Menestrina F; Martignoni G
    Pathology; 2010 Jan; 42(1):1-5. PubMed ID: 20025473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.
    Farinola MA; Epstein JI
    Hum Pathol; 2004 Oct; 35(10):1272-8. PubMed ID: 15492996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
    Zha S; Isaacs WB
    Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
    Rubin MA; Zerkowski MP; Camp RL; Kuefer R; Hofer MD; Chinnaiyan AM; Rimm DL
    Am J Pathol; 2004 Mar; 164(3):831-40. PubMed ID: 14982837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.
    Zielie PJ; Mobley JA; Ebb RG; Jiang Z; Blute RD; Ho SM
    J Urol; 2004 Sep; 172(3):1130-3. PubMed ID: 15311056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins.
    Daoud NA; Li G; Evans AJ; van der Kwast TH
    J Clin Pathol; 2012 May; 65(5):437-40. PubMed ID: 22294716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma:  A Comparison With AMACR.
    Goldstein J; Goyal R; Roland JT; Gellert LL; Clark PE; Hameed O; Giannico GA
    Am J Clin Pathol; 2016 Sep; 146(3):294-302. PubMed ID: 27543977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
    Lee WA
    Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.